Who Paid My Doc
Ph2b Type 2 Diabetes
Research payments
$600,981
Through program year 2024, $600,981 in research payments was reported against Ph2b Type 2 Diabetes, across 42 payments, paid by Amgen Inc..
- Paid by
- Amgen Inc.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
1 row| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2024 | Research | $600,981 | 42 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Alex Gonzalez Bossolo San Juan, PR Named on 3 payments
- Joel Neutel Tustin, CA Named on 2 payments
- Muhammad Irfan Tomball, TX Named on 2 payments
- Arvind Krishna Canton, OH Named on 2 payments
- Nabil Andrawis Burke, VA Named on 2 payments
- Malisa Agard Winter Park, FL Named on 2 payments
- Julio Rosenstock Dallas, TX Named on 2 payments
- Danny Sugimoto Chicago, IL Named on 2 payments
- Mark Warren Greenville, NC Named on 2 payments
- Lisa Connery Norman, OK Named on 2 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.